What is Paroxysmal nocturnal hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening blood disorder characterized by the destruction of red blood cells, blood clot formation, and impaired bone marrow function. It occurs when a genetic mutation causes blood cells to lack protective proteins, making them vulnerable to attack by the body's own immune system (the complement system).

What is the underlying cause of Paroxysmal nocturnal hemoglobinuria?

Paroxysmal nocturnal hemoglobinuria is not inherited; rather, it is a clonal disorder caused by a somatic mutation in the PIGA gene. This mutation occurs in a hematopoietic stem cell within the bone marrow, meaning it is an acquired condition. Because the PIGA gene is located on the X chromosome, a single mutation is sufficient to disrupt the production of GPI-anchored proteins. These proteins act as "shields" on the surface of blood cells. Without them, the complement system—a part of the immune system—mistakenly identifies the red blood cells as foreign and destroys them, a process known as hemolysis.

Which body systems are affected by Paroxysmal nocturnal hemoglobinuria?

While Paroxysmal nocturnal hemoglobinuria is primarily a hematologic (blood) condition, its effects are systemic. The destruction of red blood cells releases hemoglobin into the bloodstream, which can lead to severe anemia, fatigue, and dark-colored urine. Furthermore, the activation of the complement system and the release of cellular contents significantly increase the risk of thrombosis (blood clots), which is the leading cause of morbidity and mortality in Paroxysmal nocturnal hemoglobinuria patients. Clots can occur in unusual locations, such as the veins of the abdomen or the brain.

Who is typically affected and how rare is the condition?

Paroxysmal nocturnal hemoglobinuria is exceptionally rare, with an estimated global prevalence of approximately 1 to 5 per million people. It affects men and women equally and can occur at any age, though it is most frequently diagnosed in young adults between the ages of 30 and 40. There is no specific geographic or ethnic predisposition. Currently, 162 people living with Paroxysmal nocturnal hemoglobinuria have joined the DiseaseMaps community to share their experiences and support one another.

What are the key clinical features of Paroxysmal nocturnal hemoglobinuria?

The clinical presentation varies significantly between individuals. Key characteristics that help differentiate Paroxysmal nocturnal hemoglobinuria from other hemolytic anemias include:

• Hemolysis: Chronic destruction of red blood cells leading to anemia.


• Thrombosis: A heightened risk of blood clots, even in patients with low blood cell counts.


• Bone Marrow Failure: Many patients also exhibit signs of aplastic anemia or myelodysplastic syndrome.


• Smooth Muscle Dystonia: Patients may experience abdominal pain, difficulty swallowing (dysphagia), or erectile dysfunction due to nitric oxide depletion.


• Dark Urine: Often noticed in the morning, which gave the disease its historical (though often misleading) name.

Next steps

• Consult a hematologist who specializes in bone marrow failure syndromes or complement-mediated disorders.


• Request specialized flow cytometry testing to determine the "PNH clone size," which helps quantify the percentage of affected blood cells.


• Connect with the 162 members on DiseaseMaps.org to share resources and find emotional support within our rare disease community.


• Discuss current clinical trials and complement inhibitor therapies (such as C5 inhibitors) with your medical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Paroxysmal nocturnal hemoglobinuria (ORPHA:408)


• NIH Genetic and Rare Diseases Information Center (GARD): Paroxysmal nocturnal hemoglobinuria


• OMIM (Online Mendelian Inheritance in Man): PIGA gene and PNH (#300818)


• Aplastic Anemia & MDS International Foundation: PNH resources